316 related articles for article (PubMed ID: 31289826)
1. Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
Boutrot M; Azougagh K; Guinard J; Boulain T; Barbier F
J Antimicrob Chemother; 2019 Oct; 74(10):3095-3103. PubMed ID: 31289826
[TBL] [Abstract][Full Text] [Related]
2. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.
Armand-Lefèvre L; Angebault C; Barbier F; Hamelet E; Defrance G; Ruppé E; Bronchard R; Lepeule R; Lucet JC; El Mniai A; Wolff M; Montravers P; Plésiat P; Andremont A
Antimicrob Agents Chemother; 2013 Mar; 57(3):1488-95. PubMed ID: 23318796
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
4. The effects of topical antibiotics on eradication and acquisition of third-generation cephalosporin and carbapenem-resistant Gram-negative bacteria in ICU patients; a post hoc analysis from a multicentre cluster-randomized trial.
Plantinga NL; Wittekamp BHJ; Brun-Buisson C; Bonten MJM;
Clin Microbiol Infect; 2020 Apr; 26(4):485-491. PubMed ID: 31421272
[TBL] [Abstract][Full Text] [Related]
5. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
Massart N; Camus C; Benezit F; Moriconi M; Fillatre P; Le Tulzo Y
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):889-895. PubMed ID: 31898797
[TBL] [Abstract][Full Text] [Related]
7. Resistance in gram-negative bacilli in a cardiac intensive care unit in India: risk factors and outcome.
Pawar M; Mehta Y; Purohit A; Trehan N; Rosenthal VD
Ann Card Anaesth; 2008; 11(1):20-6. PubMed ID: 18182755
[TBL] [Abstract][Full Text] [Related]
8. Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia.
Villegas MV; Briceno DF; Ruiz SJ; Furtado GH; Nicolau DP
Braz J Infect Dis; 2011; 15(5):413-9. PubMed ID: 22230846
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of nosocomial pneumonia in infants after cardiac surgery.
Tan L; Sun X; Zhu X; Zhang Z; Li J; Shu Q
Chest; 2004 Feb; 125(2):410-7. PubMed ID: 14769717
[TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.
Uc-Cachón AH; Gracida-Osorno C; Luna-Chi IG; Jiménez-Guillermo JG; Molina-Salinas GM
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31540314
[No Abstract] [Full Text] [Related]
13. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program-Asia-Pacific Region.
Roberts JA; Kwa A; Montakantikul P; Gomersall C; Kuti JL; Nicolau DP
Int J Antimicrob Agents; 2011 Mar; 37(3):225-9. PubMed ID: 21168997
[TBL] [Abstract][Full Text] [Related]
15. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
16. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study.
Tacconelli E; Górska A; De Angelis G; Lammens C; Restuccia G; Schrenzel J; Huson DH; Carević B; Preoţescu L; Carmeli Y; Kazma M; Spanu T; Carrara E; Malhotra-Kumar S; Gladstone BP
Clin Microbiol Infect; 2020 Jan; 26(1):87-94. PubMed ID: 31128285
[TBL] [Abstract][Full Text] [Related]
17. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
Orrett FA
Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
[TBL] [Abstract][Full Text] [Related]
18. Long-term adherence to a 5 day antibiotic course guideline for treatment of intensive care unit (ICU)-associated Gram-negative infections.
Edgeworth JD; Chis Ster I; Wyncoll D; Shankar-Hari M; McKenzie CA
J Antimicrob Chemother; 2014 Jun; 69(6):1688-94. PubMed ID: 24573413
[TBL] [Abstract][Full Text] [Related]
19. A pharmacodynamic analysis of resistance trends in pathogens from patients with infection in intensive care units in the United States between 1993 and 2004.
Eagye KJ; Nicolau DP; Lockhart SR; Quinn JP; Doern GV; Gallagher G; Abramson MA
Ann Clin Microbiol Antimicrob; 2007 Oct; 6():11. PubMed ID: 17908321
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.
Maina JW; Mutua JM; Musyoki AM
BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
